Renaissance Technologies
RGNT

Renaissance Technologies’s Regentis Biomaterials RGNT Stock Holding History

Renaissance Technologies’s Portfolio RGNT Stock Details RGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.1K Buy
+13,348
New +$38.1K ﹤0.01% 3053

Other funds holding RGNT

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Renaissance Technologies's RGNT Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Regentis Biomaterials (RGNT) in Q2 2026: 13,348 shares worth $47.1K. The stake represents ﹤0.01% of the portfolio and ranks #3053 among its holdings.

6 funds tracked by Wall St. Rank hold RGNT as of Q2 2026.

  • Renaissance Technologies held 13,348 shares of Regentis Biomaterials worth $47.1K as of Q2 2026.
  • Regentis Biomaterials was a new Renaissance Technologies position in Q2 2026.
  • Regentis Biomaterials made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3053 holding.
  • 6 funds tracked by Wall St. Rank held Regentis Biomaterials as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.